Cargando…
Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?
Mesenchymal stromal cells (MSC) have been used to treat a broad range of disease indications such as acute and chronic inflammatory disorders, autoimmune diseases, and transplant rejection due to their potent immunosuppressive/anti-inflammatory properties. The breadth of their usage is due in no sma...
Autores principales: | Lohan, Paul, Treacy, Oliver, Griffin, Matthew D., Ritter, Thomas, Ryan, Aideen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705547/ https://www.ncbi.nlm.nih.gov/pubmed/29225601 http://dx.doi.org/10.3389/fimmu.2017.01626 |
Ejemplares similares
-
Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation
por: Lohan, Paul, et al.
Publicado: (2018) -
Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?
por: Lohan, Paul, et al.
Publicado: (2014) -
Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice
por: Treacy, Oliver, et al.
Publicado: (2021) -
Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment
por: Lynch, Kevin, et al.
Publicado: (2017) -
Immunogenicity of allogeneic mesenchymal stem cells
por: Schu, Sabine, et al.
Publicado: (2012)